Advocates for lower drug prices say a federal lawsuit filed this month against St Louis-based Express Scripts and two other companies could result in more affordable medicine for patients. The Federal ...
Money Talks News on MSN
How a major FTC settlement could lower your out-of-pocket drug costs
A landmark deal aims to end the pricing games that grossly inflate what you pay at the pharmacy.
Praluent has a list price of more than $14,000 a year. However, Express Scripts customers will be able to receive the drug for $4,500 to $6,600 annually after discounts and rebates, Express Scripts ...
Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...
Federal regulators announced a settlement Wednesday with Express Scripts to change how the company handles prescription drug ...
Dec 8 (Reuters) - Short seller Citron Research's Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the "culprit behind pharmaceutical price ...
The FTC accuses major PBMs of inflating insulin prices, impacting patient costs and access to affordable medications. PBMs prioritize high-rebate drugs, contributing to high insulin prices and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results